Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H12O6 |
Molecular Weight | 180.1559 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O
InChI
InChIKey=GZCGUPFRVQAUEE-KVTDHHQDSA-N
InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4-,5-,6-/m1/s1
DescriptionSources: http://www.douglaslabs.com/media/DL99471.pdfCurator's Comment: description was created based on several sources, including
http://www.rxlist.com/d-mannose-page2/supplements.htm | https://www.ncbi.nlm.nih.gov/pubmed/6753135 | https://www.ncbi.nlm.nih.gov/pubmed/9736238
Sources: http://www.douglaslabs.com/media/DL99471.pdf
Curator's Comment: description was created based on several sources, including
http://www.rxlist.com/d-mannose-page2/supplements.htm | https://www.ncbi.nlm.nih.gov/pubmed/6753135 | https://www.ncbi.nlm.nih.gov/pubmed/9736238
D-mannose is a simple sugar found naturally in fruits such as cranberries and pineapples. Unlike many sugars, it is not metabolised or stored in the liver. Much of it is excreted in the urine, where it interferes with particle attachment and prevents certain kind of bacteria from sticking to the walls and causing infection. Mannose supplement is also indicated for treatment of carbohydrate-deficient glycoprotein syndrome, however clinical trials failed to prove its efficacy.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4837 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15659162 |
2300.0 nM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | D-MANNOSE Approved UseD-mannose may be a useful dietary supplement for individuals wishing to support normal urinary tract health |
|||
Primary | D-MANNOSE Approved UseD-mannose is used for treating carbohydrate-deficient glycoprotein syndrome, an inherited metabolic disorder. |
PubMed
Title | Date | PubMed |
---|---|---|
Concanavalin A binding glycoprotein in human stratum corneum. | 1984 Mar |
|
Relationships between glucose and mannose during late gestation in normal pregnancy and pregnancy complicated by diabetes mellitus: concurrent concentrations in maternal plasma and amniotic fluid. | 1986 May |
|
Inhibition of cyclic AMP-dependent induction of ornithine aminotransferase by simple carbohydrates in cultured hepatocytes. | 1987 Dec |
|
Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice. | 1991 Feb |
|
Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. | 1991 Jan 2 |
|
Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. | 1992 Jan |
|
Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator. | 1992 Jul |
|
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. | 1993 Dec 1 |
|
Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij. | 2003 Aug |
|
Oolemmal proteomics--identification of highly abundant heat shock proteins and molecular chaperones in the mature mouse egg and their localization on the plasma membrane. | 2003 Feb 14 |
|
Mannose-Escherichia coli interaction in the presence of metal cations studied in vitro by colorimetric polydiacetylene/glycolipid liposomes. | 2004 Jun |
|
Functional evaluation of carbohydrate-centred glycoclusters by enzyme-linked lectin assay: ligands for concanavalin A. | 2004 Jun 7 |
|
Synthesis, characterization, and bioavailability of mannosylated shell cross-linked nanoparticles. | 2004 May-Jun |
|
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. | 2005 |
|
Acid sphingomyelinase: relation of 93lysine residue on the ratio of intracellular to secreted enzyme activity. | 2005 Aug |
|
Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. | 2005 Jul |
|
Inefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surface. | 2005 Jul 15 |
|
Carbohydrate localization on Gyrodactylus salaris and G. derjavini and corresponding carbohydrate binding capacity of their hosts Salmo salar and S. trutta. | 2005 Mar |
|
Synthesis of structurally defined scaffolds for bivalent ligand display based on glucuronic acid anilides. The degree of tertiary amide isomerism and folding depends on the configuration of a glycosyl azide. | 2005 May 13 |
|
Innate immunity: cells, receptors, and signaling pathways. | 2005 May-Jun |
|
Synthesis and transdermal penetration of NSAID glycoside esters. | 2005 Sep 14 |
|
Phosphatidylinositol mannosides: synthesis and suppression of allergic airway disease. | 2006 Aug 15 |
|
Analysis of rice glycosyl hydrolase family 1 and expression of Os4bglu12 beta-glucosidase. | 2006 Dec 29 |
|
Search for additional influenza virus to cell interactions. | 2006 Feb |
|
Catabolism of 1,5-anhydro-D-fructose in Sinorhizobium morelense S-30.7.5: discovery, characterization, and overexpression of a new 1,5-anhydro-D-fructose reductase and its application in sugar analysis and rare sugar synthesis. | 2006 Feb |
|
Synthesis of a nonavalent mannoside glycodendrimer based on pentaerythritol. | 2006 Feb 17 |
|
Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs. | 2006 Jul |
|
Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethality. | 2006 Mar 3 |
|
Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. | 2006 Nov |
|
Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: Design, synthesis and binding properties of mannoside ligands. | 2006 Nov 7 |
|
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. | 2006 Sep |
|
Design and synthesis of novel multivalent mannosides targeting the mannose receptor. | 2007 Dec 28 |
|
Engineering of PA-IIL lectin from Pseudomonas aeruginosa - Unravelling the role of the specificity loop for sugar preference. | 2007 Jun 1 |
|
Multi-mannosides based on a carbohydrate scaffold: synthesis, force field development, molecular dynamics studies, and binding affinities for lectin Con A. | 2007 Nov 23 |
|
Composition and hierarchical organisation of a spider silk. | 2007 Oct 3 |
|
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. | 2008 Apr 30 |
|
Tetra- and hexavalent mannosides inhibit the pro-apoptotic, antiproliferative and cell surface clustering effects of concanavalin-A: impact on MT1-MMP functions in marrow-derived mesenchymal stromal cells. | 2008 Feb |
|
Role of antibody paratope conformational flexibility in the manifestation of molecular mimicry. | 2008 Feb 15 |
|
EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis. | 2008 Jan |
|
Identification of hexose diastereomers by means of tandem mass spectrometry of oxocarbenium ions followed by neural networks analysis. | 2008 Jan |
|
Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. | 2008 Jan |
|
Mannoside hydrolysis: it's a boat! | 2008 May |
|
Colon cancer releases alpha-tocopherol from its O-glycosides better than normal colon tissue. | 2009 Mar-Apr |
|
In vivo expression of innate immunity markers in patients with Mycobacterium tuberculosis infection. | 2010 Aug 18 |
|
Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall. | 2010 Jan 28 |
|
Structure-based drug design and optimization of mannoside bacterial FimH antagonists. | 2010 Jun 24 |
|
Escherichia coli global gene expression in urine from women with urinary tract infection. | 2010 Nov 11 |
|
Crystal structures of a novel anti-HIV mannose-binding lectin from Polygonatum cyrtonema Hua with unique ligand-binding property and super-structure. | 2010 Sep |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.waterfall-d-mannose.com/dmannose.html
3 x 1000mg tablets every three hours for a couple of days plus a middle of the night dose is a good guide for most people who need urgent support. Reduce slowly as symptoms improve.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6753135
Two rows of serial two fold dilutions of bacterial suspension in PBS were dispensed in microtiter plates. To each well in the first row an aliquot of a yeast suspension was added; to each raw in the second row an aliquote of washed 3% human group A erythrocytes was added. The plates were gently shaken. Yeast agglutination was scored after 30 min at room temperature, hemagglutination was assessed after the plates were kept overnight at 4°C. To establish whether the agglutination was mannose sensitive or mannose resistant, the bacteria 10^9 cells/ml were suspended in PBS containing 2.5 % methyl alpha-D-mannoside prior to the assay.
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
2627 (Number of products:112)
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
||
|
LOINC |
74893-9
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
||
|
DSLD |
1365 (Number of products:1)
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
||
|
FDA ORPHAN DRUG |
666918
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
||
|
NCI_THESAURUS |
C68479
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6633
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | RxNorm | ||
|
4208
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
26247
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
161658
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
222-392-4
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
16024
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
SUB33129
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
MANNOSE
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
m7082
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB12907
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
12612
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
PHA4727WTP
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
D008358
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
DTXSID5040463
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
37684
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
530-26-7
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
ALTERNATIVE | |||
|
C83903
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
100000181429
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
37675
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
3458-28-4
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
1375182
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
208-474-2
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
ALTERNATIVE | |||
|
C1505
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
CONCEPT | Dietary Supplement | ||
|
JK-272
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY | |||
|
PHA4727WTP
Created by
admin on Fri Dec 15 14:58:51 GMT 2023 , Edited by admin on Fri Dec 15 14:58:51 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD